Literature DB >> 33817443

Wegener's granulomatosis with orbital involvement: case report and literature review.

Mirescu Andrada-Elena1, Teodora Tofolean Ioana2,3, Florica Milicescu Mihaela2,4, Cristescu Irina-Elena3, Teodor Iacob Andrei3, Baltă Florian1,2,3.   

Abstract

Objective: To describe the chronology and the extent of orbital involvement in a case of granulomatosis with polyangiitis.
Methods: Descriptive case report and literature review.
Results: A 45-year-old patient, formerly diagnosed with granulomatosis with polyangiitis due to otorhinolaryngologic manifestations, pulmonary lesions, renal impairment, left knee arthritis and high blood levels of antineutrophil cytoplasmic antibodies, addressed the Ophthalmology Department in November 2020, having the following complaints: left eye mild retro-orbital discomfort, proptosis and epiphora. On examination, Snellen's best corrected visual acuity was 6/ 6 in both eyes. The anterior segment of the left eye displayed significant changes: proptosis, upper lid swelling, ptosis, slightly decreased ocular motility, mild conjunctival hyperemia and chemosis, thinning of sclera in the upper quadrant and mild posterior subcapsular cataract. Left eye funduscopy revealed a slightly elevated optic disc, with indistinct margins in the nasal quadrant. Spectral-domain optical coherence tomography (OCT) of the optic nerve confirmed the clinical findings, illustrating an increase in the retinal nerve fiber layers thickness in the nasal quadrant, with no corresponding visual field defect. The orbit magnetic resonance imaging (MRI) unveiled an intraconal mass surrounding the optic nerve on its entire intra-orbital path, confirming the diagnosis of left orbital granuloma.
Conclusion: Considering the relapsing disease and the orbital involvement, the patient is currently a candidate for rituximab, a monoclonal antibody against CD20. Abbreviations: AAV = ANCA associated vasculitides, ANCA = antineutrophil cytoplasmic antibody, AOM = acute otitis media, BCVA = best corrected visual acuity, CRP = C-reactive protein, CT = computerized tomography, EGPA = eosinophilic granulomatosis with polyangiitis, ENT = otorhinolaryngology/ ear-nose-throat, ESR = erythrocyte sedimentation rate, GPA = granulomatosis with polyangiitis, LE = left eye, MPA = microscopic polyangiitis, MRI = magnetic resonance imaging, OCT = optical coherence tomography, RE = right eye, RNFL = retinal nerve fiber layers, TNF = tumor necrosis factor, WG = Wegener's granulomatosis. ©Romanian Society of Ophthalmology.

Entities:  

Keywords:  ANCA associated vasculitis; anti-CD20 monoclonal antibodies; granulomatosis with polyangiitis; orbital granuloma

Year:  2021        PMID: 33817443      PMCID: PMC7995507          DOI: 10.22336/rjo.2021.19

Source DB:  PubMed          Journal:  Rom J Ophthalmol        ISSN: 2457-4325


  19 in total

1.  Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Authors:  John H Stone; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cees G M Kallenberg; E William St Clair; Anthony Turkiewicz; Nadia K Tchao; Lisa Webber; Linna Ding; Lourdes P Sejismundo; Kathleen Mieras; David Weitzenkamp; David Ikle; Vicki Seyfert-Margolis; Mark Mueller; Paul Brunetta; Nancy B Allen; Fernando C Fervenza; Duvuru Geetha; Karina A Keogh; Eugene Y Kissin; Paul A Monach; Tobias Peikert; Coen Stegeman; Steven R Ytterberg; Ulrich Specks
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

Review 2.  Pathogenesis of ANCA-associated vasculitis.

Authors:  Rodrigo Cartin-Ceba; Tobias Peikert; Ulrich Specks
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 3.  Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment.

Authors:  Cloé Comarmond; Patrice Cacoub
Journal:  Autoimmun Rev       Date:  2014-08-20       Impact factor: 9.754

4.  Cyclophosphamide therapy in Wegener's granulomatosis.

Authors:  S N Novack; C M Pearson
Journal:  N Engl J Med       Date:  1971-04-29       Impact factor: 91.245

5.  Successful treatment of idiopathic orbital inflammation with mycophenolate mofetil.

Authors:  Mark P Hatton; Peter A D Rubin; C Stephen Foster
Journal:  Am J Ophthalmol       Date:  2005-11       Impact factor: 5.258

6.  The clinical and pathologic constellation of Wegener granulomatosis of the orbit.

Authors:  S R Perry; J Rootman; V A White
Journal:  Ophthalmology       Date:  1997-04       Impact factor: 12.079

7.  Mycophenolate mofetil therapy for inflammatory eye disease.

Authors:  Jennifer E Thorne; Douglas A Jabs; Faqir A Qazi; Quan Dong Nguyen; John H Kempen; James P Dunn
Journal:  Ophthalmology       Date:  2005-08       Impact factor: 12.079

8.  The binding of proteinase 3 antineutrophil cytoplasmic antibodies (PR3-ANCA) varies in different ELISAs.

Authors:  M Trevisin; P Neeson; J Savige
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

9.  B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.

Authors:  M Martinez Del Pero; A Chaudhry; R B Jones; P Sivasothy; P Jani; D Jayne
Journal:  Clin Otolaryngol       Date:  2009-08       Impact factor: 2.597

10.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.